Miguel Ángel García-Pérez
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Miguel Ángel García-Pérez has a total of 243 co-authors. Here are the top co-authors by number of shared publications:
Antonio Cano
Department of Pediatrics, Obstetrics and Gynecology, University of Valencia, Valencia, Spain
35 shared publications- Juan Tarín
Department of Cellular Biology, Functional Biology and Physical Anthropology, University of Valencia, 46100 Burjassot, Spain
35 shared publications - Antonio Cano
University of Valencia, Valencia, Spain
34 shared publications - Carlos Hermenegildo
Department of Physiology, Faculty of Medicine and Dentistry, University of Valencia and INCLIVA Biomedical Research Institute, Valencia, Spain
27 shared publications Juan J. Tarín
Department of Cellular Biology, Functional Biology and Physical Anthropology, University of Valencia, Burjassot, Spain
16 shared publicationsA. Cano
Department of Pediatrics, Obstetrics and Gynecology, University of Valencia, Valencia, Spain
13 shared publications
Latest Publications
- Open Access
- 26 February 2026
- Published by Wiley in Health Science Reports
- Vol. 9 (3)
Associations Between Reproductive Disorders and Specific Physical, Mental, Personality, and Social Characteristics: A Narrative Review
Background and Aims: The present review aims to ascertain whether reproductive disorders are associated with specific physical, mental, personality, and social traits. This information may be used to support or reject the hypothesis on the origin of infecundity, which proposes that women/men with preferred characteristics, including high resource holding potential, genetic quality, and/or reproductive potential have advantage over women/men displaying less preferred traits in selecting partners with preferred traits. Methods: A literature search of the reported associations of endometriosis, polycystic ovary syndrome, diminished ovarian reserve in women < 35 years, and low semen quality with specific physical, mental, personality, and social characteristics was carried out using the PubMed database. Results: Endometriosis is associated with lower body mass index and waist‐to‐hip ratio, greater breast‐to‐underbreast ratio, severe teenage acne, red hair, fair skin, nevi and freckles, light eyes, and high sensitivity to sun exposure. Polycystic ovary syndrome is linked to central adiposity, waist‐to‐hip ratio > 0.80, acne vulgaris, acanthosis nigricans, and hirsutism in both obese and lean women, and lower cognitive performance on memory, executive function, attention, information processing speed, and visuospatial skills. Diminished ovarian reserve in women < 35 years is associated with shorter cycle length and menstrual bleeding length, either shorter or longer than 4–6 days. Sperm quality is negatively correlated with body mass index, waist circumference, weight gain since age 17 years, extraversion, and psychoticism, but positively correlated with general intelligence. The four reproductive disorders analyzed are significantly associated with high levels of anxiety, stress, and/or depression, as well as economic burden (endometriosis) or lower socioeconomic status (polycystic ovary syndrome, diminished ovarian reserve, and low semen quality). Conclusion: This study discloses specific physical, mental, personality, and social traits associated with four reproductive disorders. More efforts are warranted to evaluate traits associated with reproductive disorders using a multiethnic and multicultural viewpoint.
- 26 February 2026
- Published by Wiley in Health Science Reports
- Vol. 9 (3)
Open AccessAssociations Between Reproductive Disorders and Specific Physical, Mental, Personality, and Social Characteristics: A Narrative Review
Background and Aims: The present review aims to ascertain whether reproductive disorders are associated with specific physical, mental, personality, and social traits. This information may be used to support or reject the hypothesis on the origin of infecundity, which proposes that women/men with preferred characteristics, including high resource holding potential, genetic quality, and/or reproductive potential have advantage over women/men displaying less preferred traits in selecting partners with preferred traits. Methods: A literature search of the reported associations of endometriosis, polycystic ovary syndrome, diminished ovarian reserve in women < 35 years, and low semen quality with specific physical, mental, personality, and social characteristics was carried out using the PubMed database. Results: Endometriosis is associated with lower body mass index and waist‐to‐hip ratio, greater breast‐to‐underbreast ratio, severe teenage acne, red hair, fair skin, nevi and freckles, light eyes, and high sensitivity to sun exposure. Polycystic ovary syndrome is linked to central adiposity, waist‐to‐hip ratio > 0.80, acne vulgaris, acanthosis nigricans, and hirsutism in both obese and lean women, and lower cognitive performance on memory, executive function, attention, information processing speed, and visuospatial skills. Diminished ovarian reserve in women < 35 years is associated with shorter cycle length and menstrual bleeding length, either shorter or longer than 4–6 days. Sperm quality is negatively correlated with body mass index, waist circumference, weight gain since age 17 years, extraversion, and psychoticism, but positively correlated with general intelligence. The four reproductive disorders analyzed are significantly associated with high levels of anxiety, stress, and/or depression, as well as economic burden (endometriosis) or lower socioeconomic status (polycystic ovary syndrome, diminished ovarian reserve, and low semen quality). Conclusion: This study discloses specific physical, mental, personality, and social traits associated with four reproductive disorders. More efforts are warranted to evaluate traits associated with reproductive disorders using a multiethnic and multicultural viewpoint.
- Open Access
- 17 January 2026
- Published by Springer Nature in Reproductive Biology and Endocrinology
- Vol. 24 (1)
Pregnancy and perinatal complications in untreated subfertile couples following singleton spontaneous conception: a narrative review
Literature shows that ovulation induction, intrauterine insemination, and assisted reproductive technology are independently associated with increased risk
- 17 January 2026
- Published by Springer Nature in Reproductive Biology and Endocrinology
- Vol. 24 (1)
Open AccessPregnancy and perinatal complications in untreated subfertile couples following singleton spontaneous conception: a narrative review
Literature shows that ovulation induction, intrauterine insemination, and assisted reproductive technology are independently associated with increased risk
- Open Access
- 1 September 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (17) , 8484
Effects of L-Arginine on Bone Metabolism: Evidence from In Vitro and In Vivo Models
Despite the rising incidence of osteoporosis (the most common bone disorder) as life expectancy increases worldwide, the genetic and metabolic factors contributing to this multifactorial disease are still poorly understood. This study investigated the role of arginine metabolism in bone formation and its potential for preventing bone loss in postmenopausal osteoporosis. The osteogenic effects of arginine were evaluated in vitro by determining calcium mineral deposition and the expression of marker genes in the human osteoblastic cell line Saos-2. In vivo analyses were conducted in ovariectomized mice treated with arginine, focusing on femoral bone microarchitecture, marker gene expression and serum metabolite profiles. Arginine treatment enhanced calcium deposition and osteoblastic differentiation in vitro. In contrast, however, this treatment had a deleterious effect in vivo, exacerbating trabecular bone loss. These results are particularly relevant given the wide availability of arginine as a dietary supplement, and our findings underscore the necessity of verifying the safety of nutritional supplements in different populations and in the presence of disease.
- 1 September 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (17) , 8484
Open AccessEffects of L-Arginine on Bone Metabolism: Evidence from In Vitro and In Vivo Models
Despite the rising incidence of osteoporosis (the most common bone disorder) as life expectancy increases worldwide, the genetic and metabolic factors contributing to this multifactorial disease are still poorly understood. This study investigated the role of arginine metabolism in bone formation and its potential for preventing bone loss in postmenopausal osteoporosis. The osteogenic effects of arginine were evaluated in vitro by determining calcium mineral deposition and the expression of marker genes in the human osteoblastic cell line Saos-2. In vivo analyses were conducted in ovariectomized mice treated with arginine, focusing on femoral bone microarchitecture, marker gene expression and serum metabolite profiles. Arginine treatment enhanced calcium deposition and osteoblastic differentiation in vitro. In contrast, however, this treatment had a deleterious effect in vivo, exacerbating trabecular bone loss. These results are particularly relevant given the wide availability of arginine as a dietary supplement, and our findings underscore the necessity of verifying the safety of nutritional supplements in different populations and in the presence of disease.
- Open Access
- 18 August 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (16) , 5834
The Final Phases of Ovarian Aging: A Tale of Diverging Functional Trajectories
Ovarian aging is characterized by a gradual decline in both reproductive and endocrine functions, ultimately culminating in the cessation of ovarian activity around the age of 50, when most women experience natural menopause. The decline begins early, as follicular attrition is initiated in utero and continues throughout childhood and reproductive life. Most follicles undergo atresia without progressing through substantial stages of growth. With increasing age, a pronounced reduction occurs in the population of resting follicles within the ovarian reserve, accompanied by a decline in the size of growing follicular cohorts. Around the age of 38, the rate of follicular depletion accelerates, sometimes resulting in diminished ovarian reserve (DOR). The subsequent menopausal transition involves complex, irregular hormonal dynamics, manifesting as increasingly erratic menstrual patterns, primarily driven by fluctuations in circulating estrogens and a rising incidence of anovulatory cycles. In parallel with the progressive depletion of the follicular pool, the serum concentrations of anti-Müllerian hormone (AMH) decline gradually, while reductions in inhibin B levels become more apparent during the late reproductive years. The concomitant decline in both inhibin B and estrogen levels leads to a compensatory rise in circulating follicle-stimulating hormone (FSH) concentrations. Together, these endocrine changes, alongside the eventual exhaustion of the follicular reserve, converge in the onset of menopause, which is defined by the absence of menstruation for twelve consecutive months. The mechanisms contributing to ovarian aging are complex and multifactorial, involving both the oocyte and the somatic cells within the follicular microenvironment. Oxidative stress is thought to play a central role in the age-related decline in oocyte quality, primarily through its harmful effects on mitochondrial DNA integrity and broader aspects of cellular function. Although granulosa cells appear to be relatively more resilient, they are not exempt from age-associated damage, which may impair their hormonal activity and, given their close functional relationship with the oocyte, negatively influence oocyte competence. In addition, histological changes in the ovarian stroma, such as fibrosis and heightened inflammatory responses, are believed to further contribute to the progressive deterioration of ovarian function. A deeper understanding of the biological processes driving ovarian aging has facilitated the development of experimental interventions aimed at extending ovarian functionality. Among these are the autologous transfer of mitochondria and stem cell-based therapies, including the use of exosome-producing cells. Additional approaches involve targeting longevity pathways, such as those modulated by caloric restriction, or employing pharmacological agents with geroprotective properties. While these strategies are supported by compelling experimental data, robust clinical evidence in humans remains limited.
- 18 August 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (16) , 5834
Open AccessThe Final Phases of Ovarian Aging: A Tale of Diverging Functional Trajectories
Ovarian aging is characterized by a gradual decline in both reproductive and endocrine functions, ultimately culminating in the cessation of ovarian activity around the age of 50, when most women experience natural menopause. The decline begins early, as follicular attrition is initiated in utero and continues throughout childhood and reproductive life. Most follicles undergo atresia without progressing through substantial stages of growth. With increasing age, a pronounced reduction occurs in the population of resting follicles within the ovarian reserve, accompanied by a decline in the size of growing follicular cohorts. Around the age of 38, the rate of follicular depletion accelerates, sometimes resulting in diminished ovarian reserve (DOR). The subsequent menopausal transition involves complex, irregular hormonal dynamics, manifesting as increasingly erratic menstrual patterns, primarily driven by fluctuations in circulating estrogens and a rising incidence of anovulatory cycles. In parallel with the progressive depletion of the follicular pool, the serum concentrations of anti-Müllerian hormone (AMH) decline gradually, while reductions in inhibin B levels become more apparent during the late reproductive years. The concomitant decline in both inhibin B and estrogen levels leads to a compensatory rise in circulating follicle-stimulating hormone (FSH) concentrations. Together, these endocrine changes, alongside the eventual exhaustion of the follicular reserve, converge in the onset of menopause, which is defined by the absence of menstruation for twelve consecutive months. The mechanisms contributing to ovarian aging are complex and multifactorial, involving both the oocyte and the somatic cells within the follicular microenvironment. Oxidative stress is thought to play a central role in the age-related decline in oocyte quality, primarily through its harmful effects on mitochondrial DNA integrity and broader aspects of cellular function. Although granulosa cells appear to be relatively more resilient, they are not exempt from age-associated damage, which may impair their hormonal activity and, given their close functional relationship with the oocyte, negatively influence oocyte competence. In addition, histological changes in the ovarian stroma, such as fibrosis and heightened inflammatory responses, are believed to further contribute to the progressive deterioration of ovarian function. A deeper understanding of the biological processes driving ovarian aging has facilitated the development of experimental interventions aimed at extending ovarian functionality. Among these are the autologous transfer of mitochondria and stem cell-based therapies, including the use of exosome-producing cells. Additional approaches involve targeting longevity pathways, such as those modulated by caloric restriction, or employing pharmacological agents with geroprotective properties. While these strategies are supported by compelling experimental data, robust clinical evidence in humans remains limited.
- Open Access
Association of the rs17782313, rs17773430 and rs34114122 Polymorphisms of/near MC4R Gene with Obesity-Related Biomarkers in a Spanish Pediatric Cohort
Obesity is a multifactorial disease whose onset and development are shaped by the individual genetic background. The melanocortin 4 receptor gene (MC4R) is involved in the regulation of food intake and energy expenditure. Some of the single nucleotide polymorphisms (SNPs) of this gene are related to obesity and metabolic risk factors. The present study was undertaken to assess the relationship between three polymorphism SNPs, namely, rs17782313, rs17773430 and rs34114122, and obesity and metabolic risk factors. One hundred seventy-eight children with obesity aged between 7 and 16 years were studied to determine anthropometric variables and biochemical and inflammatory parameters. Our results highlight that metabolic risk factors, especially alterations in carbohydrate metabolism, were related to rs17782313. The presence of the minor C allele in the three variants (C–C–C) was significantly associated with anthropometric measures indicative of obesity, such as the body mass and fat mass indexes, and increased the values of insulinemia to 21.91 µIU/mL with respect to the wild type values. Our study suggests that the C–C–C haplotype of the SNPs rs17782313, rs17773430 and rs34114122 of the MC4R gene potentiates metabolic risk factors at early ages in children with obesity.
Open AccessAssociation of the rs17782313, rs17773430 and rs34114122 Polymorphisms of/near MC4R Gene with Obesity-Related Biomarkers in a Spanish Pediatric Cohort
Obesity is a multifactorial disease whose onset and development are shaped by the individual genetic background. The melanocortin 4 receptor gene (MC4R) is involved in the regulation of food intake and energy expenditure. Some of the single nucleotide polymorphisms (SNPs) of this gene are related to obesity and metabolic risk factors. The present study was undertaken to assess the relationship between three polymorphism SNPs, namely, rs17782313, rs17773430 and rs34114122, and obesity and metabolic risk factors. One hundred seventy-eight children with obesity aged between 7 and 16 years were studied to determine anthropometric variables and biochemical and inflammatory parameters. Our results highlight that metabolic risk factors, especially alterations in carbohydrate metabolism, were related to rs17782313. The presence of the minor C allele in the three variants (C–C–C) was significantly associated with anthropometric measures indicative of obesity, such as the body mass and fat mass indexes, and increased the values of insulinemia to 21.91 µIU/mL with respect to the wild type values. Our study suggests that the C–C–C haplotype of the SNPs rs17782313, rs17773430 and rs34114122 of the MC4R gene potentiates metabolic risk factors at early ages in children with obesity.
- Open Access
Genetic variants of the vitamin D receptor are related to dynapenia in postmenopausal women